A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424 by Woodcock, V, Clive, S, Wilson, R, Coyle, V, Stratford, M, Folkes, L, Eastell, R, Barton, C, Jones, P, Kazmi-Stokes, S, Turner, H, Halford, S, Harris, A, Middleton, M